Llew Keltner is Director at Raptor Pharmaceutical Corp (RPTP). They have made 1 open-market trade across 1 company since 2012, most recently 2016-10-25.
CIK 0001298076
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $837 since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RPTP | 8,330 | — |
Shares reported on the most recent Form 4, priced at the 2016-10-26 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RPTP | SELL · 10b5-1 | 2015-07-01 | 2015-07-02 | $16.05 | $803K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2014-07-07 | 2014-07-09 | $11.21 | $112K | N/A | N/A | N/A |
| RPTP | BUY | 2014-05-30 | 2014-06-03 | $8.37 | $837 | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2014-03-07 | 2014-03-11 | $15.73 | $157K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2014-01-07 | 2014-01-09 | $13.25 | $133K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2013-11-07 | 2013-11-12 | $14.05 | $140K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2012-11-26 | 2012-11-27 | $5.00 | $5K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2012-09-17 | 2012-09-18 | $5.49 | $5K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2012-08-01 | 2012-08-02 | $5.00 | $5K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2012-05-15 | 2012-05-16 | $5.49 | $5K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2012-03-15 | 2012-03-16 | $6.99 | $7K | N/A | N/A | N/A |
| RPTP | SELL · 10b5-1 | 2012-02-15 | 2012-02-16 | $7.74 | $7K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.